ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.728,42
-0,05%
S&P 500
5.228,72
0,14%
Dow Jones
39.439,12
0,02%
Euro vs US Dollar
1,08228
0,26%
Bitcoin
61.910,32
-1,58%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NYSE
  6. Bio Rad Laboratories Inc (BIO.B)

  7. Bio Rad Laboratories Inc (BIO.B) News

BIO.B

Bio Rad Laboratories (BIO.B)

Bio Rad Laboratories Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NYSE:BIO.B
DatumZeitQuelleÜberschriftSymbolFirma
18/04/202415h00Business WireBio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024NYSE:BIO.BBio Rad Laboratories Inc
10/04/202422h15Business WireBio-Rad’s Chief Operating Officer Andrew Last to RetireNYSE:BIO.BBio Rad Laboratories Inc
11/03/202414h59Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:BIO.BBio Rad Laboratories Inc
29/02/202423h24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BIO.BBio Rad Laboratories Inc
29/02/202400h38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BIO.BBio Rad Laboratories Inc
29/02/202400h24Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:BIO.BBio Rad Laboratories Inc
27/02/202423h39Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:BIO.BBio Rad Laboratories Inc
27/02/202423h35Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:BIO.BBio Rad Laboratories Inc
21/02/202422h31Edgar (US Regulatory)Form 8-K - Current reportNYSE:BIO.BBio Rad Laboratories Inc
16/02/202422h31Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NYSE:BIO.BBio Rad Laboratories Inc
15/02/202422h24Edgar (US Regulatory)Form 8-K - Current reportNYSE:BIO.BBio Rad Laboratories Inc
15/02/202422h15Business WireBio-Rad Reports Fourth-Quarter and Full-Year 2023 Financial ResultsNYSE:BIO.BBio Rad Laboratories Inc
14/02/202423h01Edgar (US Regulatory)Form 8-K - Current reportNYSE:BIO.BBio Rad Laboratories Inc
13/02/202423h00Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:BIO.BBio Rad Laboratories Inc
29/01/202423h25Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:BIO.BBio Rad Laboratories Inc
19/12/202318h19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BIO.BBio Rad Laboratories Inc
14/12/202317h40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BIO.BBio Rad Laboratories Inc
13/12/202301h43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BIO.BBio Rad Laboratories Inc
13/12/202300h24Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:BIO.BBio Rad Laboratories Inc
08/12/202320h33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BIO.BBio Rad Laboratories Inc
08/12/202301h14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BIO.BBio Rad Laboratories Inc
07/12/202323h01Edgar (US Regulatory)Form 8-K - Current reportNYSE:BIO.BBio Rad Laboratories Inc
07/12/202322h26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BIO.BBio Rad Laboratories Inc
28/11/202323h48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BIO.BBio Rad Laboratories Inc
28/11/202322h53Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:BIO.BBio Rad Laboratories Inc
28/11/202321h48Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:BIO.BBio Rad Laboratories Inc
02/11/202316h28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BIO.BBio Rad Laboratories Inc
27/10/202322h31Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:BIO.BBio Rad Laboratories Inc
27/10/202322h31Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:BIO.BBio Rad Laboratories Inc
26/10/202322h17Edgar (US Regulatory)Form 8-K - Current reportNYSE:BIO.BBio Rad Laboratories Inc
 Showing the most relevant articles for your search:NYSE:BIO.B

Kürzlich von Ihnen besucht

TG
NOV
Novo Nordisk
NYSE
NKE
Nike
CCOM
US100
US Tech 100
NYSE
KO
Coca Cola
DBI
TDXP
Tec DAX
USOTC
BASFY
BASF (QX)
CCOM
SILVER
SILVER
USOTC
DTEGY
Deutsche Telekom (QX)
NYSE
MCD
McDonalds
TG
DTE
Deutsche Telekom
NASDAQ
GOOGL
Alphabet
DBI
SDXP
SDAX
PM
XAUUSD
Gold vs US Dollar
AMEX
XLE
Energy Select Sector SPDR
NASDAQ
MSFT
Microsoft
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten